CFN
IONS icon

Cordasco Financial Network’s Ionis Pharmaceuticals IONS Stock Holding History

Cordasco Financial Network’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-200
Closed -$8K – 568
2021
Q2 		$8K Buy
+200
New +$7.83K 0.01% 413

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cordasco Financial Network's IONS Position: Q3 2021 in Review

Cordasco Financial Network sold out of Ionis Pharmaceuticals (IONS) in Q3 2021, closing a stake of 200 shares — an estimated $8K sold.

Cordasco Financial Network first reported a position in IONS in Q2 2021 and held it in 1 quarter. The position peaked at $8K in Q2 2021. 324 funds tracked by Wall St. Rank hold IONS as of Q3 2021.

  • Cordasco Financial Network reported no remaining Ionis Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Cordasco Financial Network sold 200 Ionis Pharmaceuticals shares in Q3 2021, an estimated $8K.
  • Cordasco Financial Network first reported a position in Ionis Pharmaceuticals in Q2 2021 and held it in 1 quarter.
  • Cordasco Financial Network's Ionis Pharmaceuticals position peaked at $8K in Q2 2021.
  • 324 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2021.

Based on Cordasco Financial Network's 13F filing for Q3 2021, filed 12 Nov 2021.